Related references
Note: Only part of the references are listed.Insights into the Biosynthesis of 12-Membered Resorcylic Acid Lactones from Heterologous Production in Saccharomyces cerevisiae
Yuquan Xu et al.
ACS CHEMICAL BIOLOGY (2014)
TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation
Sho Morioka et al.
JOURNAL OF CELL BIOLOGY (2014)
Synthetic Phosphorylation of p38α Recapitulates Protein Kinase Activity
K. Phin Chooi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Positive Feedback Within a Kinase Signaling Complex Functions as a Switch Mechanism for NF-κB Activation
Hisaaki Shinohara et al.
SCIENCE (2014)
Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma
S. M. Ansell et al.
BLOOD CANCER JOURNAL (2014)
Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol
Jiaquan Wu et al.
ACS CHEMICAL BIOLOGY (2013)
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
Yihui Fan et al.
APOPTOSIS (2013)
Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1
Keith R. Hornberger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics
Keith R. Hornberger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition
Y. Dondelinger et al.
CELL DEATH AND DIFFERENTIATION (2013)
TAK1 Inhibition in the DFG-Out Conformation
Iain Kilty et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Qingsong Liu et al.
CHEMISTRY & BIOLOGY (2013)
Target validation using chemical probes
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2013)
Mechanism and consequence of the autoactivation of p38α mitogen-activated protein kinase promoted by TAB1
Gian Felice De Nicola et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
In Vivo Knockdown of TAK1 Accelerates Bone Marrow Proliferation/Differentiation and Induces Systemic Inflammation
Paul M. Vink et al.
PLOS ONE (2013)
Essential role of TAK1 in regulating mantle cell lymphoma survival
Daniela Buglio et al.
BLOOD (2012)
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Anurag Singh et al.
CELL (2012)
Identification of Type-II Inhibitors Using Kinase Structures
Frank Lovering et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
How Chemoproteomics Can Enable Drug Discovery and Development
Raymond E. Moellering et al.
CHEMISTRY & BIOLOGY (2012)
Cis-enone Resorcylic Acid Lactones (RALs) as Irreversible Protein Kinase Inhibitors
Linyi Wei et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
TAK1 Negatively Regulates NF-κB and p38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils
Adebusola Alagbala Ajibade et al.
IMMUNITY (2012)
Essential Role for IKKβ in Production of Type 1 Interferons by Plasmacytoid Dendritic Cells
Eduardo Pauls et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Fully Functionalized Small-Molecule Probes for Integrated Phenotypic Screening and Target Identification
Justin S. Cisar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
Nicolas Dzamko et al.
PLOS ONE (2012)
Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function
Yanyan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Oxindole derivatives as inhibitors of TAK1 kinase
Jeffrey W. Lockman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
A comprehensive overview on genomically directed assembly of aromatic polyketides and macrolide lactones using fungal megasynthases
Takayoshi Saruwatari et al.
JOURNAL OF ANTIBIOTICS (2011)
Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease
David S. Millan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Resorcylic Acid Lactones with Cytotoxic and NF-κB Inhibitory Activities and Their Structure-Activity Relationships
Sloan Ayers et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
Davide Melisi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The Prevalence of TNFα-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay
Seda Coel Arslan et al.
PLOS ONE (2011)
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells
Gabriel Courties et al.
BLOOD (2010)
In Vivo Efficacy of Natural Product-Inspired Irreversible Kinase Inhibitors
Sofia Barluenga et al.
CHEMBIOCHEM (2010)
Transforming Growth Factor β-activated Kinase 1 (TAK1) Kinase Adaptor, TAK1-binding Protein 2, Plays Dual Roles in TAK1 Signaling by Recruiting Both an Activator and an Inhibitor of TAK1 Kinase in Tumor Necrosis Factor Signaling Pathway
Peter Broglie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
Thomas Ryckmans et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A critical role of TAK1 in B-cell receptor-mediated nuclear factor κB activation
James Schuman et al.
BLOOD (2009)
Synthesis of a Resorcylic Acid Lactone (RAL) Library Using Fluorous-Mixture Synthesis and Profile of its Selectivity Against a Panel of Kinases
Rajamalleswaramma Jogireddy et al.
CHEMISTRY-A EUROPEAN JOURNAL (2009)
Epoxyquinol B, a naturally occurring pentaketide dimer, inhibits NF-κB signaling by crosslinking TAK1
Hiroshi Kamiyama et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Activity-based protein profiling for the functional annotation of enzymes
Katherine T. Barglow et al.
NATURE METHODS (2007)
Chemistry and biology of resorcylic acid lactones
Nicolas Winssinger et al.
CHEMICAL COMMUNICATIONS (2007)
TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells
Shintaro Sato et al.
INTERNATIONAL IMMUNOLOGY (2006)
TAK1-mediated stress signaling pathways are essential for TNF-α-promoted pulmonary metastasis of murine colon cancer cells
MK Choo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides
A Schirmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
JH Shim et al.
GENES & DEVELOPMENT (2005)
Essential function for the kinase TAK1 in innate and adaptive immune responses
S Sato et al.
NATURE IMMUNOLOGY (2005)
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes
LJ Sun et al.
MOLECULAR CELL (2004)
Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling
T Ishitani et al.
EMBO JOURNAL (2003)
Feedback control of the protein kinase TAK1 by SAPK2a/p38α
PCF Cheung et al.
EMBO JOURNAL (2003)
A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase
J Ninomiya-Tsuji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein family annotation in a multiple alignment viewer
JM Johnson et al.
BIOINFORMATICS (2003)
TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
G Takaesu et al.
MOLECULAR CELL (2000)
Share Paper
